Patients
Getting in the driver’s seat: Sharron’s AMKD story
3 min read
Hear Sharron Rouse’s first-hand experience living with APOL1-mediated kidney disease (AMKD); how it prompted her to be an active participant in her own health and how her family supported her — emotionally and physically — in her journey.
Patients
A nephrologist’s perspective on APOL1-mediated kidney disease
2 min read
Dr. Ogo Egbuna leads clinical development for our genetic kidney disease programs. Learn more about APOL1-mediated kidney disease from a nephrologist’s perspective.
Science and Innovation
Targeting genetic kidney disease
1 min read
APOL1-mediated kidney disease (AMKD) is a serious disease with a high unmet need — exactly the type of problem that fits our research strategy. Hear from experts in our AMKD podcast episode, in partnership with Bloomberg Media Studios.